Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

NCT03361735 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma

Interventions

DRUG: Leuprolide Acetate
DRUG: Goserelin Acetate
RADIATION: Stereotactic Body Radiation Therapy
RADIATION: Radium Ra 223 Dichloride
OTHER: Laboratory Biomarker Analysis
DRUG: Degarelix

Sponsor

City of Hope Medical Center